Qkine
Private Company
Total funding raised: $11.3M
Overview
Qkine is a private, revenue-generating biotechnology tools company providing essential, high-quality protein reagents to the life sciences research and development sector. Operating from Cambridge, UK, its core business is the manufacturing and sale of optimized growth factors and cytokines, with a focus on supporting advanced cell culture systems like stem cells and organoids. The company positions itself as a critical enabler for emerging fields such as cellular agriculture, organ-on-a-chip, and cell therapy by guaranteeing bioactivity and lot-to-lot consistency. Its products are manufactured to GMP-grade equivalent standards, making them suitable for translational and pre-clinical applications.
Technology Platform
Animal-free recombinant protein manufacturing platform with protein engineering for enhanced bioactivity, stability, and purity. Includes GMP-grade equivalent production under ISO standards.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Qkine competes in the research reagents space against giants like Thermo Fisher, Merck, and STEMCELL Technologies, as well as numerous specialty protein suppliers. Its differentiation is based on superior bioactivity, application-specific optimization, and a focus on animal-free, high-purity formats for advanced cell culture, rather than breadth of catalog or lowest price.